• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number PB 10
Device Problems Gradient Increase (1270); Perivalvular Leak (1457); Incomplete Coaptation (2507)
Patient Problems Fistula (1862); Hematoma (1884); Hemothorax (1896); Insufficiency, Valvular (1926); Mitral Regurgitation (1964); Blood Loss (2597); Vascular Dissection (3160)
Event Date 11/20/2018
Event Type  Injury  
Manufacturer Narrative
Citation: joseph ta et al.Long-term outcomes of melody valve-in-valve implantation for bioprosthetic mitral valve dysfunction.Catheter cardiovasc interv.2019 may 1;93(6):1087-1094.Doi: 10.1002/ccd.27988.Epub 2018 nov 20.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the long-term outcomes in patients with degenerated mitral bioprosthetic valves who were treated with transcatheter valve-in-valve implantation using the melody valve.All data were retrospectively collected from a single center between july 2011 and october 2013.The study population included 13 patients and was predominantly female with a mean age of 75 years.Of those, 3 were previously implanted with medtronic surgical valves in the mitral position: hancock (1) and mosaic (2).All patients underwent valve-in-valve implantation with a 22 mm medtronic melody transcatheter valve.No serial number were provided.Among all patients, 6 deaths occurred during follow-up.The reported causes of death were: septic shock and pneumonia (1), lymphoma (1), possible sudden cardiac death (1), and unknown causes (3).Based on the available information, medtronic product was not directly associated with the deaths.For the hancock patient (patient 3), adverse events included: mitral regurgitation that required valve-in-valve implantation 10 years after the hancock valve was implanted.Based on the available information, medtronic product was directly associated with the adverse event.For the mosaic patients, adverse events included: mitral regurgitation that required valve-in-valve implantation 4 years after the mosaic valve was implanted (patient 9), and mitral stenosis that required valve-in-valve implantation 8 years after the mosaic valve was implanted (patient 12).Based on the available information, medtronic product was directly associated with the adverse events.Adverse events observed after melody valve-in-valve implantation: severe mitral regurgitation caused by a loss of leaflet coaptation that required a repeat transcatheter valve-in-valve procedure (4.4 years after initial valve-in-valve), right iliac artery dissection with retroperitoneal bleeding that required surgical repair, thigh hematoma that required endovascular therapy, hemothorax that required chest tube drainage and blood transfusion, arterio-venous fistula, mild-moderate-severe mitral regurgitation, trace paravalvular leak, and increased mean transvalvular gradients.Based on the available information, medtronic product was directly associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MELODY TRANSCATHETER PULMONARY VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key9511386
MDR Text Key187044792
Report Number2025587-2019-03867
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 12/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPB 10
Device Catalogue NumberPB 10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/03/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-